The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock
Abstract
OBJECTIVE: To investigate the physiologic effects of exogenous vasopressin as a potential alternative to traditional high-dose catecholamine therapy for septic patients with vascular hyporeactivity to catecholamines. DESIGN: Prospective, case-controlled study. SETTING: Intensive care unit of a university hospital. PATIENTS: Vasopressin was infused in 16 critically ill septic patients who remained persistently hypotensive despite infusions of pharmacologic doses of catecholamines. INTERVENTION: Continuous intravenous infusion of vasopressin at 0.04 units/min for 16 hrs, in place of escalating the amount of catecholamines being infused. MEASUREMENTS AND MAIN RESULTS: After administration of vasopressin, systemic vascular resistance and mean arterial pressure were immediately and significantly increased in comparison with the values obtained just before vasopressin. When the vasopressin infusions were discontinued, mean arterial pressure decreased immediately and dramatically. We did not detect any obvious adverse cardiac effects during the vasopressin infusions. Vasopressin had no effect on other hemodynamic parameters or any of the metabolic parameters studied, including measures of oxygenation, plasma glucose, or electrolytes. Urine output increased significantly during the administration of vasopressin, although this effect may be nonspecific. Lactate concentrations decreased, particularly in the survival group, but the decreases were not significant. Overall survival was 56%. CONCLUSIONS: Low-dose vasopressin infusions increased mean arterial pressure, systemic vascular resistance, and urine output in patients with vasodilatory septic shock and hyporesponsiveness to catecholamines. The data indicate that low-dose vasopressin infusions may be useful in treating hypotension in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Bakker, J., Gris, P., Coffernils, M., Kahn, R. J., & Vincent, J.-L. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)89552-9 · Cited by 851
Low-Dose Vasopressin in the Treatment of Vasodilatory Septic Shock
Malay, M. B., Ashton, R. C., Landry, D. W., & Townsend, R. N. (1999) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199910000-00014 · Cited by 391
Vasopressin pressor hypersensitivity in vasodilatory septic shock
Landry, D. W., Levin, H. R., Gallant, E. M., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00012 · Cited by 390
Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels
Edwards, R. M. (1983) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1983.244.5.f526 · Cited by 283
Heyndrickx, G., Boettcher, D., & Vatner, S. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.231.5.1579 · Cited by 239
Reversal by Vasopressin of Intractable Hypotension in the Late Phase of Hemorrhagic Shock
Morales, D., Madigan, J., Cullinane, S., Chen, J., Heath, M., Oz, M., Oliver, J. A., & Landry, D. W. (1999) · Circulation · doi:10.1161/01.cir.100.3.226 · Cited by 225
Bone, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540070061032 · Cited by 224
Pharmacology and clinical perspectives of vasopressin antagonists.
László, F. A., László, F., & De Wied, D. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06661-x · Cited by 213
Cited by
Brierley, J., Carcillo, J. A., Choong, K., Cornell, T., DeCaen, A., Deymann, A., Doctor, A., Davis, A., Duff, J., Dugas, M.-A., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819323c6 · Cited by 1,073
Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study
Dünser, M. W., Mayr, A. J., Ulmer, H., Knotzer, H., Sumann, G., Pajk, W., Friesenecker, B., & Hasibeder, W. R. (2003) · Circulation · doi:10.1161/01.cir.0000066692.71008.bb · Cited by 525
Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update
Hollenberg, S. M., Ahrens, T. S., Annane, D., Astiz, M. E., Chalfin, D. B., Dasta, J. F., Heard, S. O., Martin, C., Napolitano, L. M., Susla, G. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139761.05492.d6 · Cited by 521
Adrenal insufficiency during septic shock*
Marik, P. E., & Zaloga, G. P. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00022 · Cited by 379
Pseudomonas aeruginosa -Catecholamine Inotrope Interactions
Freestone, P. P., Hirst, R. A., Sandrini, S. M., Sharaff, F., Fry, H., Hyman, S., & O'Callaghan, C. (2012) · Chest · doi:10.1378/chest.11-2614 · Cited by 107
Metadata
- Authors
- Tsuneyoshi, I., Yamada, H., Kakihana, Y., Nakamura, M., Nakano, Y., & Boyle, W. A.
- Venue
- Critical Care Medicine
- Published
- 2001-03
- Volume
- 29
- Issue
- 3
- Pages
- 487-493
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2035917666
- Cited by
- 592
- References
- 27
- FWCI
- 82.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. https://app.cochat.ai/papers/10.1097/00003246-200103000-00004
- The paper
- Tsuneyoshi, I., Yamada, H., Kakihana, Y., Nakamura, M., Nakano, Y., & Boyle, W. A. (2001). Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Critical Care Medicine. https://doi.org/10.1097/00003246-200103000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.